Ardelyx, Inc. (ARDX) Financial Statements
Industry: Pharmaceutical Preparations
In fiscal 2025, Ardelyx reported revenue of $407.3M, up 22.1% from $333.6M the year before. Net income was -$61.6M (a -15.1% net margin), or -$0.26 per diluted share. Gross margin was 90.3% and operating margin was -10.1%. Operating activities generated -$42.5M of cash, leaving -$44.0M of free cash flow. At fiscal year end, Ardelyx held $501.6M in total assets against $334.7M in total liabilities, including $68.0M of cash and equivalents.
Open the full interactive Ardelyx financials → Quarterly statements, key ratios, valuation history and price charts.
Ardelyx Key Stats
| Share Price | $3.12 |
|---|---|
| Market Cap | $774.0M |
| Revenue YoY Growth | +22.1% |
| 52-Week Range | $3.12 – $7.99 |
| Shares Outstanding | 248.1 million (basic, 2026 Q2) |
Ardelyx Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $7.6M | $10.1M | $52.2M | $124.5M | $333.6M | $407.3M |
| Cost of Goods Sold | $98.4M | $164.4M | $115.9M | $17.8M | $50.6M | $39.5M |
| Gross Profit | $7.4M | $9.1M | $48.0M | $106.7M | $283.1M | $367.8M |
| Operating Income | -$90.8M | -$154.3M | -$63.8M | -$63.3M | -$27.9M | -$41.0M |
| Pre-Tax Income | -$94.3M | -$158.2M | -$67.2M | -$65.5M | -$38.9M | -$60.6M |
| Income Tax | $2,000 | $4,000 | $8,000 | $547,000 | $266,000 | $969,000 |
| Net Income | -$94.3M | -$158.2M | -$67.2M | -$66.1M | -$39.1M | -$61.6M |
| Diluted EPS | -$1.05 | -$1.52 | -$0.42 | -$0.30 | -$0.17 | -$0.26 |
Ardelyx Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $110.3M | $125.2M | $94.5M | $120.9M |
| Net Income | -$969,000 | -$407,000 | -$37.6M | -$16.7M |
| Diluted EPS | — | -$0.00 | -$0.15 | -$0.07 |
Ardelyx Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $91.0M | $72.4M | $96.1M | $21.5M | $64.9M | $68.0M |
| Current Assets | $194.7M | $133.6M | $153.6M | $246.1M | $356.5M | $382.3M |
| Total Assets | $201.6M | $149.9M | $190.1M | $297.6M | $435.8M | $501.6M |
| Current Liabilities | $28.4M | $52.8M | $65.6M | $50.4M | $77.8M | $88.6M |
| Total Long-Term Debt | $50.8M | $32.3M | $26.7M | $49.8M | $150.9M | $202.8M |
| Total Liabilities | $75.5M | $67.3M | $91.7M | $130.8M | $262.5M | $334.7M |
| Shareholders' Equity | $126.1M | $82.6M | $98.3M | $166.8M | $173.3M | $166.9M |
Ardelyx Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | -$81.4M | -$152.6M | -$70.0M | -$89.7M | -$44.8M | -$42.5M |
| Cash From Investing | -$31.4M | $50.9M | $18.4M | -$131.2M | -$18.3M | -$9.0M |
| Cash From Financing | $22.8M | $83.0M | $75.3M | $146.3M | $106.6M | $54.5M |
| Free Cash Flow | -$81.8M | -$154.4M | -$70.1M | -$90.1M | -$45.8M | -$44.0M |
Figures from Ardelyx's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Ardelyx financials page for every line item.
Ardelyx Company Profile
| Ticker | ARDX |
|---|---|
| Exchange | Nasdaq |
| Industry | Pharmaceutical Preparations |
| Headquarters | Fremont, California |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Large accelerated filer |
| SEC CIK | 0001437402 |
Frequently Asked Questions
What was Ardelyx's revenue in fiscal 2025?
Ardelyx (ARDX) reported revenue of $407.3M for fiscal 2025.
What is Ardelyx's annual revenue history?
Ardelyx's annual revenue by fiscal year: 2020: $7.6M; 2021: $10.1M; 2022: $52.2M; 2023: $124.5M; 2024: $333.6M; 2025: $407.3M.
What was Ardelyx's net income in fiscal 2025?
Ardelyx reported net income of -$61.6M for fiscal 2025.
What was Ardelyx's earnings per share (EPS) in fiscal 2025?
Ardelyx's diluted EPS was -$0.26 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Ardelyx generate in fiscal 2025?
Ardelyx generated -$44.0M of free cash flow in fiscal 2025.
What was Ardelyx's revenue last quarter?
In its most recent reported quarter (2026 Q2), Ardelyx reported revenue of $120.9M.
How much debt does Ardelyx have?
Ardelyx reported $202.8M of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of Ardelyx are outstanding?
Ardelyx reported a weighted average of 248.1 million basic shares outstanding in 2026 Q2.
What is Ardelyx's market cap?
Based on its latest closing price, Ardelyx (ARDX) has a market capitalization of about $774.0M.
When does Ardelyx's fiscal year end?
Ardelyx's fiscal year end, as registered with the SEC, is December 31.
Where is Ardelyx headquartered?
Ardelyx lists its business address in Fremont, California in its SEC filings.